Chronic pouchitis Program in Pharmaceutical Benefits Scheme (PBS) 012-24110514
Expand allThis document outlines details of PBS-subsidised vedolizumab for patients with moderate to severe chronic pouchitis.
Chronic pouchitis and listing dates
Pouchitis is inflammation of the lining of the small intestinal pouch created during surgery to remove the colon. Chronic pouchitis is the most common long-term complication of ileal pouch-anal anastomosis (IPAA) surgery which is often used to treat ulcerative colitis and some other digestive conditions.
Listing date: vedolizumab - 1 December 2024.
See Written Authority Required Drugs for more details.
Enquiries
Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.
The Resources page contains:
- application forms
- contact details
- restriction and item codes
- FAQs from Service Officers
- the PBS schedule
- Services Australia website link
Related links
Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)
Process telephone Authority approval application
Processing and National Demand Allocation (PaNDA)
Processing Complex Authority Required Listings
Processing Written Authority requests
Written Authority Required Drugs